Autologous blood stem cell transplantation as therapy for autoimmune diseases

References

• Marmont A. Immune ablation followed by allogenic auto-logous bone marrow transplantation: a new treatment for severe autoimmune diseases? Stem Cells 1994; 12: 125–35.
   PubMed Web of Science ®Google Scholar
• Burt R. BMT for severe autoimmune diseases: an idea whose time has come. Oncology 1997; 11: 1001–17.
   PubMedGoogle Scholar
• Snowden J, Brooks P, Biggs J. Haemopoietic stem cell transplantation for autoimmune diseases. Br j Haematol 1997; 99: 9–22.
   PubMed Web of Science ®Google Scholar
• Marmont AM. Stem cell transplantation for severe auto-immune diseases: progress and problems. Haematologica 1998; 83: 733–43.
   PubMed Web of Science ®Google Scholar
• Joske DJL. Autologous bone-marrow transplantation for rheumatoid arthritis. Lancet 1997; 350: 337–8.
   PubMed Web of Science ®Google Scholar
• Snowden JA, Biggs JC, Milliken ST, Fuller A, Brookes PM. A phase I/11 dose escalation study of intensified cyclo-phosphamide and autologous blood stem cell rescue in severe active rheumatoid arthritis. Arthritis Rheum 1999; 42: 2286–92.
   PubMed Web of Science ®Google Scholar
• Moore JJ, Passuello E The Australian Bone Marrow Transplant in Rheumatoid Arthritis Study Group. Peripheral Blood Stem Cell Transplantation for Rheumatoid Arthritis - the Australian Multicentre Randomised trail (abstract). Blood 1999; 94 Suppl 1: 354a.
   Google Scholar
• Bingham SJ, Snowden JA, McGonagle D, Richards S, Isaacs J, Morgan G, et al. Autologous stem cell transplantation for rheumatoid arthritis - report of six patients. J Rheum (in press).
   Google Scholar
• Durez P, Toungouz M, Schandene L, Lambermont, Goldman M. Remission and immune reconstitution after T-cell depleted stem cell transplantation for rheumatoid arthritis. Lancet 1998; 352: 881.
   PubMedGoogle Scholar
• Durez P, Ferster A, Poungouz M, Schandene L, Kentos A, Lambermont M, et al. Autologous T cell depleted CD34+ peripheral blood stem cell transplantation in four patients with refractory rheumatoid arthritis and juvenile chronic arthritis. Arthritis Rheum 1999; 42 Suppl: S77.
   Google Scholar
• McColl G, Kohsaka H, Wicks I. High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999; 131: 507–9.
   PubMed Web of Science ®Google Scholar
• Wulffraat N, van Royen A, Biering M, Vossen J, Kuis W. Autologous haemopoietic stem cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999; 353: 550–3.
   PubMed Web of Science ®Google Scholar
• Vleiger AM, Brinkman D, Quartier P, Prieur A, van Cate R, Bierings M, et al. Infection associated MAS in 3 patients receiving ASCT for refractory juvenile chronic arthritis. Bone Marrow Transplant 2000; 25 (Suppl): S81.
   Google Scholar
• Martini A, Maccario R, RaveIli A, Montagna D, Benedetti F, Bonetti F, et al. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum 1999; 42: 807–11.
   PubMed Web of Science ®Google Scholar
• Van den Hoogen F, van Laar J, Schattenburg A, Fibbe W, Preijers F, Breedveld F, et al. High dose cyclophosphamide followed by autologous peripheral blood stem cell trans-plantation for the treatment of systemic sclerosis. Arthritis Rheum 1999; 42 Suppl: S169.
   Google Scholar
• Euler H, Marmont A, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht, et al. Early recurrence or persistence of auto-immune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621–5.
   PubMed Web of Science ®Google Scholar
• Marmont AM, van Lint MT, Gualandi F, Bacigalupo A. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997; 6: 545–8.
   PubMed Web of Science ®Google Scholar
• Traynor A, Schroeder J, Rosa M, Mujais S, Rosen S, Bowyer S, et al. Stem cell transplantation for resistant lupus. Arthritis Rheum 1999; 42: S170.
   Web of Science ®Google Scholar
• Heipe F, Rosen 0, Thiel A, Massenkeil G, Radtke H, Haupl T, et al. Successful treatment of refractory systemic lupus erythematosus (SI.E) by autologous stem cell transplantation (ASCT) with in vivo immunomodulation and ex vivo depletion of mononuclear cells. Arthritis Rheum 1999; 42: S170.
   Google Scholar
• Wulffraat N, Vlieger AM, Kamphuis SM, Sanders EAM, Kuis W. Autologous stem cell transplantation in two patients with juvenile SLE. Bone Marrow Transplant 2000; 25 (Suppl): S114.
   Google Scholar
• Bingham S, Emery P, McGonagle D, Isaacs J, Griffiths B, Morgan G, et al. Leeds experience of stem cell trans-plantation for autoimmune disease (abstract). Ann Rheum Dis 1999; Suppl: S219.
   Google Scholar
• Rosen o, Massenkeil T, Haupl F, Heipe G, Burmester H, Radtke A, et al. Autologous stem cell transplantation (ASCT) in refractory autoimmune disease (AID): induction of remission. Bone Marrow Transplant 1999; Suppl: S36.
   Google Scholar
• Hensel M, Schlenk A, Breitbart AD. High-dose chemo-therapy with melphalan followed by autologous hemato-poietic stem cell transplantation in two patients with Behcet's disease. Bone Marrow Transplant 2000; 25 Suppl: S113.
   Google Scholar
• Myllykangas-Luosujärvi R, Jantunen E, Kaipiainen-Seppänen 0, Mahlamäki E, Nousiainen T. Autologous stem cell transplantation in patients with severe rheumatic diseases: a pilot study. Bone Marrow Transplant 2000; 25 Suppl: S112.
   Google Scholar
• Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, et al. Autologous stem cell transplantation in progressive multiple sclerosis - an interim analysis on efficacy. J Clin Immunol 2000; 20: 24–30.
   PubMedGoogle Scholar
• Burt R, Burns WH, Cohen B, Kahn L, Lobeck, Schroeder J, et al. T cell depleted autologous hematopoietic stem cell transplantation in patients with severe autoimmune diseases. Blood 1998; 92 Suppl: 324a.
   Google Scholar
• Burt RK, Burns W, Cohen B, Karlin K, Cobeck L, Brush M, et al. Results of a recently completed phase I study of autologous haemopoietic stem cell transplantation (HSCT) for multiple sclerosis. Blood 1999; 94 (Suppl 1): 354a.
   Google Scholar
• Baldwin JL, Storb R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977; 20: 1043–8.
   PubMed Web of Science ®Google Scholar
• Snowden J, Kearney P, Kearney A, Cooley H, Grigg A, Jacobs P, et al. Long-term outcome of autoimmune disease following allogenic bone marrow transplantation. Arthritis Rheum 1998; 41: 453–9.
   PubMed Web of Science ®Google Scholar
• Meloni G, Capria S, Vignetti M, Mandelli F, Moderna V. Blast crisis of chronic myelogenous leukaemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood 1997; 89: 4659.
   PubMed Web of Science ®Google Scholar
• Kashyap A, Forman S. Autologous bone marrow trans-plantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease. Br J Haematol 1998; 103: 651–2.
   PubMed Web of Science ®Google Scholar
• Tyndal A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the European League Against Rheuma-tism (EULAR) and the European Group for Blood and Bone Marrow Transplantation (EBMT). Br J Rheumatol 1997; 36: 390–2.
   Google Scholar
• Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P, et al. Autologous haemopoietic stem cell trans-plants for autoimmune disease - feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell project for Autoimmune Disease. Bone Marrow Transplant 1999; 24: 729–34.
   PubMed Web of Science ®Google Scholar
• Binks M, Passweg J, Black C, Prentice HG, Furst D, McSweeney PA, et al. Improvement of progressive skin disease, but high early mortality in scleroderma following autologous haemopoietic stem cell transplantation. Bone Marrow Transplant 1999; Suppl: S280.
   Google Scholar
• Bingham S, Emery P. Resistant rheumatoid arthritis clinics - a necessary development. Rheumatology 2000; 39: 2–5.
   Google Scholar
• Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, et al. A randomised, blinded, placebo controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998; 22: 1035–41.
   PubMed Web of Science ®Google Scholar
• Kashyap A, Openshaw H, Stuve 0, Ante! J, Lund BT, Weiner LP, et al. Autologous stem cell transplantation (ASCT) for multiple sclerosis (MS). Increase in disease activity with G-CSF use. Blood 1999; 94 (Suppl 1): 330a.
   Google Scholar
• Marmont AM. Immune ablation and stem cell trans-plantation for severe Evans syndrome and refractory thrombocytopenic pupura. Bone Marrow Transplant 1999; 23: 1215–6.
   Google Scholar
• Raetz E, Beatty PG and Adams RH. Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant 1997; 20: 427–9.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Sensenbrenner LL, Jones RJ. Complete re-mission in severe aplastic anaemia after high dose cyclo-phosphamide without bone marrow transplantation. Blood 1996; 87: 491–4.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, et al. Immunoablative high dose cyclophosphamide without stem cell rescue for refractory, severe autoimmune disease. Ann Intern Med 1998; 129: 1031–5.
   PubMed Web of Science ®Google Scholar
• Petri M, Jones A, Brodsky RA. High-dose immunoablative cyclophosphamide in SLE. Arthritis Rheum 1999; 42 (Suppl): S170.
   Google Scholar